| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,460 | $60 | $85.9K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 220 | $130 | $29.7K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 180 | $160 | $29.2K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 280 | $70 | $19.5K |
| 55700 | Code deleted December 31, 2025. | 40 | $170 | $6.6K |
| 52356 | The provider performs a cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra and into… | 20 | $310 | $6.5K |
| 76872 | The provider inserts an ultrasound probe into the rectum and performs a transrectal ultrasound to assess disorders of the prostate, rectum, and surrounding tissues. | 50 | $100 | $4.9K |
| 52235 | The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder; he destroys… | 20 | $210 | $4.5K |
| 52441 | Using a cystourethroscope, the provider places a single permanent adjustable transprostatic implant to retract prostatic lobes that obstruct the urethra. | 30 | $150 | $4.3K |
| 52442 | In this add–on procedure, the provider uses a cystourethroscope to place an additional permanent adjustable transprostatic implant to retract prostatic lobes that obstruct the urethra. | 110 | $40 | $4.1K |